[Cardiac involvement in Duchenne muscular dystrophy]

Area of Science:

• Genetics
• Cell Biology
• Neuromuscular Disorders

Context:

• Duchenne muscular dystrophy (DMD) is the most common X-linked dystrophinopathy, affecting 1 in 3500 newborn boys.
• Caused by the absence of dystrophin, a critical cytoskeleton protein essential for cellular integrity and signal transduction.
• The disease locus is mapped to the Xp21 region of the X chromosome.

Purpose:

• To summarize the key aspects of Duchenne muscular dystrophy, including its genetic basis, clinical manifestations, and current management strategies.
• To highlight the importance of early detection and multidisciplinary care in improving patient outcomes.
• To briefly touch upon emerging research directions like gene therapy.

Summary:

• DMD results from a lack of dystrophin, leading to peripheral muscle damage, calf pseudohypertrophy, and often severe cardiac and respiratory complications.
• Subclinical cardiac damage can be detected using Doppler examination of myocardial tissue.
• Management requires a multidisciplinary approach, with medical treatments for cardiac issues mirroring those for chronic heart failure.

Impact:

• Provides a concise overview of DMD for researchers, clinicians, and potentially patients and families.
• Emphasizes the critical role of dystrophin and the consequences of its absence.
• Underscores the need for ongoing research, including gene therapy, to address this severe condition.